Ali Asif 4

What Happened

• Ali Asif, Chief Financial Officer of Protagonist Therapeutics (PTGX), sold 1,750 shares on April 20, 2026. The shares were disposed at $105.47 per share, for proceeds of approximately $184,573. The filing lists the sale as an open-market or private sale and notes the shares were sold to cover a tax withholding obligation tied to the settlement of restricted stock units (RSUs).

Key Details

• Transaction date and price: 2026-04-20 at $105.47 per share.
• Shares sold / proceeds: 1,750 shares for ~$184,573.
• Shares owned after transaction: Not disclosed in the provided filing.
• Footnote: Sale made to cover tax withholding on RSU settlement (footnote F1).
• Trading plan/other codes: No 10b5-1 plan or other trading program indicated; transaction coded as S (sale) with F (tax withholding).
• Filing timeliness: Filed on 2026-04-21 for a 2026-04-20 transaction—no late filing indicated.

Context

• This was a sale to satisfy tax withholding related to RSU settlement, a routine administrative transaction that does not necessarily reflect a change in the insider’s long-term view. Sales to cover taxes are common and should be interpreted differently than discretionary open-market sales intended to divest holdings.